Recurrent episodes of pneumonia are associated with worse lung function in people with HIV
Sven J Walderich1, Jessica Fitzpatrick-Collins2, Aryana Bates2
1Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States of America.
Background:
HIV is associated with a decreased diffusing capacity for carbon monoxide (DLco), decreased spirometry, and an increased risk for developing obstructive lung disease, even in never-smokers. Pneumonia is a risk factor for impaired pulmonary function in people with HIV (PWH), but whether recurrent pneumonia results in a commensurate decline in lung function is unknown.
Methods:
We reviewed the electronic medical records and PFT data for PWH in San Francisco, CA. Participants were categorized by number of pneumonias since HIV diagnosis. We analyzed the association between the number of pneumonias and lung function using linear and logistic regression models after adjusting for substance use and HIV-associated factors.
Results:
Among 259 participants, the mean age was 51 years, 15% were female, and 42% were current smokers. One hundred (39%) participants had no prior pneumonia, 52 (20%) had 1 pneumonia, 50 (19%) had 2 pneumonias and 57 (22%) had ≥3 pneumonias. Multiple pneumonias were associated with a stepwise decline in FEV1, FVC, and DLCO %predicted (p-trend <0.001 for all) when controlling for demographic and clinical covariates. Having ≥3 pneumonias was associated with 2.84 higher odds of airflow obstruction (post-bronchodilator FEV1/FVC < LLN, 95% CI 1.02, 8.23) as well as 5.53 higher odds of impaired DLco (DLco < LLN, 95% CI 2.29, 14.0) compared to those who never had pneumonia. There were no significant differences in PFT outcomes between participants with bacterial pneumonia versus Pneumocystis pneumonia during their first episode.
Conclusion:
In PWH with a high prevalence of inhalational substance use, recurrent episodes of pneumonia are associated with a commensurate decline in lung function in PWH characterized by airflow obstruction and diffusion limitations. While further studies are needed to elucidate the underlying mechanism, this work highlights the importance of preventing recurrent pneumonia in PWH in order to preserve lung function.
More Related Videos
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...